Ivan Wasserman Quoted in “FDA Sets Meeting to Clarify DSHEA Definitions”
Following FDA’s announcement of a public meeting that will delve into definitional questions that figure into the filing of new dietary ingredient notifications, Ivan Wasserman spoke with SupplySide Supplement Journal. “I’m thrilled that the FDA has called this important meeting to continue the dialog that was started at a public meeting several years ago,” Ivan said. “I hope and believe that FDA will be an active listener and will work cooperatively with the industry to bring greater clarity to these questions that have lingered for so long.”Click here to learn more.
